347 related articles for article (PubMed ID: 27441547)
1. Unmasking the Effects of L-DOPA on Rapid Dopamine Signaling with an Improved Approach for Nafion Coating Carbon-Fiber Microelectrodes.
Qi L; Thomas E; White SH; Smith SK; Lee CA; Wilson LR; Sombers LA
Anal Chem; 2016 Aug; 88(16):8129-36. PubMed ID: 27441547
[TBL] [Abstract][Full Text] [Related]
2. Overoxidized polypyrrole-coated carbon fiber microelectrodes for dopamine measurements with fast-scan cyclic voltammetry.
Pihel K; Walker QD; Wightman RM
Anal Chem; 1996 Jul; 68(13):2084-9. PubMed ID: 9027223
[TBL] [Abstract][Full Text] [Related]
3. Biocompatible PEDOT:Nafion composite electrode coatings for selective detection of neurotransmitters in vivo.
Vreeland RF; Atcherley CW; Russell WS; Xie JY; Lu D; Laude ND; Porreca F; Heien ML
Anal Chem; 2015 Mar; 87(5):2600-7. PubMed ID: 25692657
[TBL] [Abstract][Full Text] [Related]
4. A novel electrochemical approach for prolonged measurement of absolute levels of extracellular dopamine in brain slices.
Burrell MH; Atcherley CW; Heien ML; Lipski J
ACS Chem Neurosci; 2015 Nov; 6(11):1802-12. PubMed ID: 26322962
[TBL] [Abstract][Full Text] [Related]
5. Optimized Fabrication of Carbon-Fiber Microbiosensors for Codetection of Glucose and Dopamine in Brain Tissue.
Forderhase AG; Ligons LA; Norwood E; McCarty GS; Sombers LA
ACS Sens; 2024 May; 9(5):2662-2672. PubMed ID: 38689483
[TBL] [Abstract][Full Text] [Related]
6. Peculiarities of L: -DOPA treatment of Parkinson's disease.
Kostrzewa RM; Nowak P; Kostrzewa JP; Kostrzewa RA; Brus R
Amino Acids; 2005 Mar; 28(2):157-64. PubMed ID: 15750845
[TBL] [Abstract][Full Text] [Related]
7. Amperometric detection of dopamine in vivo with an enzyme based carbon fiber microbiosensor.
Njagi J; Chernov MM; Leiter JC; Andreescu S
Anal Chem; 2010 Feb; 82(3):989-96. PubMed ID: 20055419
[TBL] [Abstract][Full Text] [Related]
8. Chronic L-DOPA therapy alters central serotonergic function and L-DOPA-induced dopamine release in a region-dependent manner in a rat model of Parkinson's disease.
Navailles S; Bioulac B; Gross C; De Deurwaerdère P
Neurobiol Dis; 2011 Feb; 41(2):585-90. PubMed ID: 21092759
[TBL] [Abstract][Full Text] [Related]
9. Real-time monitoring of electrically evoked catecholamine signals in the songbird striatum using in vivo fast-scan cyclic voltammetry.
Smith AR; Garris PA; Casto JM
J Chem Neuroanat; 2015; 66-67():28-39. PubMed ID: 25900708
[TBL] [Abstract][Full Text] [Related]
10. A pulmonary formulation of L-dopa enhances its effectiveness in a rat model of Parkinson's disease.
Bartus RT; Emerich D; Snodgrass-Belt P; Fu K; Salzberg-Brenhouse H; Lafreniere D; Novak L; Lo ES; Cooper T; Basile AS
J Pharmacol Exp Ther; 2004 Aug; 310(2):828-35. PubMed ID: 15039453
[TBL] [Abstract][Full Text] [Related]
11. Chronic intermittent L-DOPA treatment induces changes in dopamine release.
Lundblad M; af Bjerkén S; Cenci MA; Pomerleau F; Gerhardt GA; Strömberg I
J Neurochem; 2009 Feb; 108(4):998-1008. PubMed ID: 19196428
[TBL] [Abstract][Full Text] [Related]
12. Carbon nanotube-modified microelectrodes for simultaneous detection of dopamine and serotonin in vivo.
Swamy BE; Venton BJ
Analyst; 2007 Sep; 132(9):876-84. PubMed ID: 17710262
[TBL] [Abstract][Full Text] [Related]
13. Effect of tricyclic antidepressants on L-DOPA-induced dyskinesia and motor improvement in hemi-parkinsonian rats.
Conti MM; Goldenberg AA; Kuberka A; Mohamed M; Eissa S; Lindenbach D; Bishop C
Pharmacol Biochem Behav; 2016 Mar; 142():64-71. PubMed ID: 26791104
[TBL] [Abstract][Full Text] [Related]
14. Fast-scan cyclic voltammetry demonstrates that L-DOPA produces dose-dependent, regionally selective bimodal effects on striatal dopamine kinetics in vivo.
Harun R; Hare KM; Brough EM; Munoz MJ; Grassi CM; Torres GE; Grace AA; Wagner AK
J Neurochem; 2016 Mar; 136(6):1270-1283. PubMed ID: 26611352
[TBL] [Abstract][Full Text] [Related]
15. Direct in Vivo Electrochemical Detection of Resting Dopamine Using Poly(3,4-ethylenedioxythiophene)/Carbon Nanotube Functionalized Microelectrodes.
Taylor IM; Patel NA; Freedman NC; Castagnola E; Cui XT
Anal Chem; 2019 Oct; 91(20):12917-12927. PubMed ID: 31512849
[TBL] [Abstract][Full Text] [Related]
16. Denervation and repeated L-DOPA induce complex regulatory changes in neurochemical phenotypes of striatal neurons: implication of a dopamine D1-dependent mechanism.
St-Hilaire M; Landry E; Lévesque D; Rouillard C
Neurobiol Dis; 2005 Nov; 20(2):450-60. PubMed ID: 15896973
[TBL] [Abstract][Full Text] [Related]
17. Effect of l-DOPA on local field potential relationship between the pedunculopontine nucleus and primary motor cortex in a rat model of Parkinson's disease.
Geng X; Wang X; Xie J; Zhang X; Wang X; Hou Y; Lei C; Li M; Han H; Yao X; Zhang Q; Wang M
Behav Brain Res; 2016 Dec; 315():1-9. PubMed ID: 27515286
[TBL] [Abstract][Full Text] [Related]
18. Effect of repeated L-DOPA, bromocriptine, or lisuride administration on preproenkephalin-A and preproenkephalin-B mRNA levels in the striatum of the 6-hydroxydopamine-lesioned rat.
Henry B; Crossman AR; Brotchie JM
Exp Neurol; 1999 Feb; 155(2):204-20. PubMed ID: 10072296
[TBL] [Abstract][Full Text] [Related]
19. Voltammetric detection of 5-hydroxytryptamine release in the rat brain.
Hashemi P; Dankoski EC; Petrovic J; Keithley RB; Wightman RM
Anal Chem; 2009 Nov; 81(22):9462-71. PubMed ID: 19827792
[TBL] [Abstract][Full Text] [Related]
20. β-asarone and levodopa coadministration increases striatal levels of dopamine and levodopa and improves behavioral competence in Parkinson's rat by enhancing dopa decarboxylase activity.
Huang L; Deng M; Zhang S; Lu S; Gui X; Fang Y
Biomed Pharmacother; 2017 Oct; 94():666-678. PubMed ID: 28787702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
